Evidence map›Paper›PMID 33096260›Full record

ArticleAnaesthesia, critical care & pain medicine2020

Vaccines against COVID-19.

Camille Locht

Abstract readEditorial
In one paragraph

Article in Anaesthesia, critical care & pain medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. COVID-19 Vaccinating Russian Medical Students-Challenges and Solutions: A Cross-Sectional Study.International journal of environmental research and public health · 2022
    Article
  5. Normalized COVID-19 prevention and control management.Journal of family medicine and primary care · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Commentary of the mRNA vaccines COVID-19.Asian journal of pharmaceutical sciences · 2021
    Article
  12. Review
  13. Review
  14. Review
  15. Nucleic Acid-Based Technologies Targeting Coronaviruses.Trends in biochemical sciences · 2021
    Review
  16. Review
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Camille LochtUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France. Electronic address: camille.locht@pasteur-lille.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug DevelopmentAdenoviridaeAntibodies, NeutralizingClinical Trials as TopicCOVID-19COVID-19 VaccinesHumansRNA, MessengerSARS-CoV-2Vaccines, InactivatedAntibodies, NeutralizingCOVID-19 VaccinesRNA, MessengerVaccines, InactivatedAdenovirusmRNA vaccineNeutralising antibodies

Identifiers

PMID33096260
PMCPMC7574838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.